QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room

Similar documents
USRDS UNITED STATES RENAL DATA SYSTEM

Chapter 6: Transplantation

Chapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished

5FM QFMUQ? AFGJB?Q FC PC?JJW GQ 5FM QCRQ FGK GL FGQ AMLQRCJJ?RGML?LB NSRQ RFC KC?QSPGLE PMB MD BGQR?LAC GL FGQ F?LB

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

morbidity & mortality

FOUR. Clinical Indicators of Care

patient characteriuics Chapter Two introduction 58 increasing complexity of the patient population 60 epo use & anemia in the pre-esrd period 62

Chapter 7: ESRD among Children, Adolescents, and Young Adults

Chapter IX. Pediatric End Stage Renal Disease. Incidence of Reported Pediatric ESRD

FULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

THIS chapter presents basic information about

USRDS UNITED STATES RENAL DATA SYSTEM

04 Chapter Four Treatment modalities. Experience does not err, it is only your judgement that errs in expecting from her what is not in her power.

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Chapter Five Clinical indicators & preventive health

Chapter IV. Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD

Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin

Ashberyh CHAPTER. John

preventive health care measure

Status of the CKD and ESRD treatment: Growth, Care, Disparities

NINE Preventive Health Care Measures

Introduction to Volume 2: ESRD in the United States

CHAPTER 5. Paediatric Renal Replacement Therapy

Chapter 2: Identification and Care of Patients with CKD

2011 Dialysis Facility Report

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE

chapter seven transplantation page

2008 Dialysis Facility Report

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions

Levertovh CHAPTER. Denise

Chapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

2012 Dialysis Facility Report

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

USRDS UNITED STATES RENAL DATA SYSTEM

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE

2010 Dialysis Facility Report

Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities

Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities

USRDS UNITED STATES RENAL DATA SYSTEM

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

Chapter Two Incidence & prevalence

Arches National Park, Utah. hospitalization

Renal Transplant Registry Report 2008

Annual Statistics on Organ Replacement in Canada

USRDS UNITED STATES RENAL DATA SYSTEM

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

Thanks to our Speaker!

United States Renal Data System (USRDS) International Data Collection Form

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Chapter 5: Acute Kidney Injury

Chapter 15: Causes of Death on Renal Replacement Therapy

Chapter 6: Healthcare Expenditures for Persons with CKD

economic cous of esrd Chapter Twelve introduction 190 overall costs of esrd 192 incident patient costs 194 trends in the medicare program 196

Chapter 9: Cardiovascular Disease in Patients With ESRD

Chapter 10: Dialysis Providers

CHAPTER 5 RENAL TRANSPLANTATION

Chapter 6: Medicare Expenditures for CKD

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

Current status of kidney and pancreas transplantation in the United States,

ESRD Dialysis Prevalence - One Year Statistics

Hong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver

Chapter 3: Morbidity and Mortality in Patients with CKD

Chapter 8: Cardiovascular Disease in Patients with ESRD

Disparities in Transplantation Caution: Life is not fair.

CHAPTER 14. Renal Transplantation

chapter two clinical indicators and preventive care page

Dialysis outcomes: can we do better?

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES OMB No

ANEMIA & HEMODIALYSIS

Chapter 2 End-Stage Renal Disease: Scope and Trends

Yeatsh CHAPTER. William Butler

For more information about how to cite these materials visit

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS

CHAPTER 6 PERITONEAL DIALYSIS

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Rosnawati Yahya

Chapter IV. Incidence and Causes of Treated ESRD. Methods

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES OMB No

Lesson #7: Quality Assessment and Performance Improvement

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation

North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2005 Annual Report. Renal Transplantation. Chronic Renal Insufficiency

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Transcription:

QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room msix PEDIATrIC ESrD

18 ž 21 ATLAS OF ESRD IN THE UNITED STATES Incident rates of ESRD in children have risen two to three percent over the past decade, and the odds of developing ESRD are as much as 2.2 times greater in some states than in others (fig 6.2). The primary causes of ESRD in pediatric patients are glomerulonephritis and cystic/congenital/hereditary s. Boys have a higher likelihood of renal failure from these latter causes than do girls (fig 6.4). The modalities for treatment of pediatric ESRD vary with patient age and particularly with race (figs 6.9 1). White pediatric patients are more likely to receive a renal transplant than patients in other racial groups, and non-whites are twice as likely to be on hemodialysis as whites. After two years on ESRD treatment black children have an almost equal chance of being treated with either dialysis or transplant whereas more than 6% of white children have 1991-1993 1994-1996 1997-1999 Counts Incident PrevAlent Incident PrevAlent Incident PrevAlent - 4 493 1,165 52 1,262 529 1,216 5-9 38 2,258 452 2,468 423 2,581 1-14 686 3,78 785 4,453 84 4,812 15-19 1,423 7,14 1,644 8,221 1,616 8,747 RAtes per million population received a transplant. Some of these disparities may be partially explained by the availability of organs for renal transplants, as demonstrated in Chapter Seven (figs 7.1 and 7.3). Since ESRD incidence rates are two to three times higher for black children than for whites, the organ donation rates from the general population would need to be at a comparable rate for there to be a similar proportion of transplants. The ability to match an organ immunologically may also be different in black children compared to whites. Most young patients with a first renal transplant receive that transplant from a living donor, a pattern opposite to that in the adult population. Children with a repeat renal transplant, in contrast, Table 6.1 Incident & prevalent counts & rates For patients younger than ten there was little variation in incident and prevalent rates per million population through the 199s. For older pediatric patients, in contrast, prevalent rates have risen, possibly a reflection of improved - 4 8.3 19.6 8.4 21.3 9.1 21. 5-9 6.8 4.1 7.7 42. 7. 42.4 1-14 12.5 66.8 13.4 76.9 14.2 81.1 15-19 26.3 133.7 28.4 144.2 26.5 144.1 survival after transplantation (see Chapter Seven). are more likely to receive a cadaveric organ (fig 6.11). Pediatric patients younger than five have a 93% survival rate after transplantation in contrast to a 69% rate for children of the same age on dialysis (fig 6.12). Other pediatric age groups have five-year survivals on dialysis of greater than 81% (fig 6.12). Hospitalizations for children are directly related to age (figs 6.15 17) and are dominated by infectious complications. Although the number of prevalent deaths is low, female children are generally at a greater risk than males regardless of modality (figs 6.18 2). The reasons for these differences have not been explored, but may be related to a higher degree of anemia in girls than in boys. At initiation of dialysis children have lower hematocrits than adults (fig 2.39), with female children having the lowest levels. These findings are present even though children are the most likely to receive EPO before ESRD, as documented on the Medical Evidence form 2728 (fig 2.25). These associations suggest that girls may be iron deficient to a greater degree than boys or adults. Also, the prolonged and more severe anemia may predispose these children to a greater risk of myocardial hypertrophy and subsequent fibrosis, which could place them at risk for arrhythmic disorders. Further investigations are needed to more completely understand the pathobiology of these patients.

CHAPTER 6 ž PEDIATRIC ESRD ž 19 15-19 3 25 RAte per million population 2 15 1 5 199 1991 1992 1-14 1993 1994 5-9 1995 1996 1997 1998-4 1999 Figure 6.1 Incident rates, by age per million population, adjusted for gender & race Incident rates of ESRD for pediatric patients aged 4 increased slightly from 199 to 1999, as did the rates for children aged 1 14. 15.7+ (2.3) 14.3 to <15.7 13.2 to <14.3 11.6 to <13.2 below 11.6 (9.3) Figure 6.2 Incident rates, ages 19 per million population, 1995 1999 combined, adjusted for age, gender, & race, by state The mean incident rate varies by 118% between the lowest and highest quintiles. Included in this chapter A graph of incident rates, and graphs of patient distribution by modality, primary diagnosis, gender, race, and age Graphs showing treatment modality two years following the onset of ESRD A graph of the number of first and repeat transplants, and Kaplan-Meier survival curves Graphs of hospital admissions for infection, by modality, age, and gender Graphs of causes of death by gender and race

11 ž 21 ATLAS OF ESRD IN THE UNITED STATES Figure 6.3 Incident rates, by race, age, & gender, unadjusted Black pediatric patients across all age groups have higher incident rates of end-stage renal compared to patients in other racial groups, with the highest incident rates among pediatric patients occurring in blacks aged 15 19. Rate per million population 7 6 5 4 3 2 Ages -4 Ages 5-9 Ages 1-14 Ages 15-19 1 White Black N Am Asian White Black N Am Asian White Black N Am Asian White Black N Am Asian Figure 6.4 Number of patients within primary diagnosis group, by gender: dialysis incident patients aged 19, 1995 1999 combined Glomerulonephritis and cystic/ hereditary/congenital s are the most frequent primary diagnoses in the pediatric ESRD population, with both occurring more in boys than girls. Number of patients 9 8 7 6 5 4 3 2 1 Diabetes Glomerulonephritis (GN) Secondary GN/ vasculitis Interstitial nephritis Hypertension Cystic/hereditary/ congenital Neoplasm/ cancer Figure 6.5 Number of patients within primary diagnosis group, by gender: transplant incident patients aged 19, 1995 1999 combined In the pediatric patients who receive a transplant as their initial modality, cystic/hereditary/ congenital s are the primary cause of ESRD, and occur in more than twice as many boys as girls. Number of patients 32 28 24 2 16 12 8 4 Diabetes Glomerulonephritis (GN) Secondary GN/ vasculitis Interstitial nephritis Hypertension Cystic/hereditary/ congenital Neoplasm/ cancer

CHAPTER 6 ž PEDIATRIC ESRD ž 111 Percent of patients with diagnosis 6 5 4 3 2 1 Diabetes Glomerulonephritis Secondary GN/vasculitis Interstitial nephritis/pyelonephritis Hypertension Cystic/hereditary/congenital Neoplasms/cancer Figure 6.6 Distribution of primary diagnosis within racial group: dialysis incident patients aged 19, 1995 1999 combined Glomerulonephritis is the most frequent primary diagnosis in black, Native American, and Asian pediatric patients. Cystic/ hereditary/congenital s occur most often in young white and Native American patients, while Asian children are almost twice as likely than children of other races to have a primary diagnosis of secondary glomerulonephritis/vasculitis. White Black Native American Asian Percent of patients with diagnosis 8 7 6 5 4 3 2 1 Diabetes Glomerulonephritis Secondary GN/vasculitis Interstitial nephritis/pyelonephritis Hypertension Cystic/hereditary/congenital Neoplasms/tumors Figure 6.7 Distribution of primary diagnosis within racial group: transplant incident patients aged 19, 1995 1999 combined Cystic/hereditary/congenital is by far the most frequent diagnosis among pediatric patients who receive a transplant at the beginning of ESRD. No Native American or Asian patients with diabetes, secondary glomerulonephritis/ vasculitis, interstitial nephritis/ pyelonephritis, or neoplasms/ tumors were reported. White Black Native American Asian Percent of patients with diagnosis 8 7 6 5 4 3 2 1 Dialysis DM GN SGN Inst. HTN Cyst. Neopl. Transplant DM GN SGN Inst. HTN Cyst. Neopl. Figure 6.8 Gender distribution within primary diagnosis group incident patients aged 19, 1995 1999 combined Diabetes, glomerulonephritis, secondary glomerulonephritis, interstitial nephritis/pyelonephritis, hypertension, cystic/hereditary/congenital s, and neoplasms/tumors are abbreviated along the axis. Distribution within primary diagnosis categories differs greatly between the modalities. Girls account for 61% of diabetic children on dialysis, and 68% of those with secondary glomerulonephritis. Among transplant patients, however, boys account for 75% of diabetics, and the population with secondary glomerulonephritis is split evenly between the genders.

112 ž 21 ATLAS OF ESRD IN THE UNITED STATES Figure 6.9 Treatment modality two years following ESRD onset, within age group incident patients aged 19, 1995 1997 combined At two years following the onset of ESRD, transplant is by far the most frequent modality among all pediatric age groups. Among patients aged 5 9, 72% have received a transplant; that number is 47%, however, among patients aged 15 19, and 36% of patients in this age group are on hemodialysis two years after beginning ESRD. Percent of patients 1 9 8 7 6 5 4 3 2 Hemodialysis Peritoneal dialysis Transplant Death 1-4 5-9 1-14 15-19 Figure 6.1 Treatment modality two years following ESRD onset, within race group incident patients aged 19, 1995 1997 combined White children are most likely to have received a transplant by the end of their second year of ESRD, followed by Native Americans. The percentage of black and Asian children with a transplant at two years is only slightly higher than that of their peers on hemodialysis. Percent of patients 1 9 8 7 6 5 4 3 Hemodialysis Peritoneal dialysis Transplant Death 2 1 White Black Native American Asian Figure 6.11 Total first & repeat transplants, by donor source incident patients aged 19 Includes patients not eligible for Medicare enrollment. The number of transplants in 1994, and the percent change between 1994 and 1999, are indicated next to the lines. First transplantation rates among pediatric patients have been relatively steady for transplants from living donors, while the rate of cadaveric transplants declined from 1994 to 1998. Both rates increased in 1999. The number of living unrelated transplants in pediatric patients is extremely small, and reduced organ availability limits the number of repeat transplants in these patients. Number of transplants 5 45 4 35 3 25 2 15 1 5 First transplants Living (365, 22.7%) Cadaver (38, -5.5%) 1994 1995 1996 1997 1998 1999 15 125 1 75 5 25 Repeat transplants Cadaver (19, -24.8%) Living (28, -3.6%) 1994 1995 1996 1997 1998 1999

CHAPTER 6 ž PEDIATRIC ESRD ž 113 1 Dialysis First transplant Figure 6.12 Kaplan-Meier five-year patient survival, by age incident dialysis & transplant patients, 1993 1994 combined Percent surviving 9 8 7 Ages -4 Ages 5-9 Ages 1-14 Ages 15-19 By five years after the start of ESRD, 69% of children whose ESRD began between birth and age 4 are still alive on dialysis, compared to 82% of children in other age groups. For patients who receive their first transplant, survival is best for those aged 1 14 years and lowest for those aged 4 years. All age groups, however, have over 93% survival at five years. 6 12 24 36 48 6 Months of survival 12 24 36 48 6 1 White Black Figure 6.13 Kaplan-Meier five-year patient survival after first transplantation, by race & gender: cadaveric transplants 1993 1994 combined Percent surviving 9 8 1 9 Ages -4 Ages 5-9 Ages 1-14 Ages 15-19 Because of the small number of patients, data are not shown for Native American or Asian patients. The lowest five-year survival probabilities for cadaveric transplants occur in black and male patients aged 4. Overall, children aged 1 14 have the highest probabilities of survival across racial and gender groups. 8 12 24 36 48 6 12 24 36 48 6 Months of survival White 1 Black Figure 6.14 Kaplan-Meier five-year patient survival after first transplantation, by race & gender: living donor transplants 1993 1994 combined Percent surviving 9 8 1 Ages -4 Ages 5-9 Ages 1-14 Ages 15-19 Because of the small number of patients, data are not shown for Native American or Asian patients. Survival probabilities for pediatric patients receiving transplants from living donors are similar across age groups for whites and for males. 9 8 12 24 36 48 6 Months of survival 12 24 36 48 6

114 ž 21 ATLAS OF ESRD IN THE UNITED STATES Figure 6.15 Admissions for infection (overall), by age, gender, & time on ESRD: hemodialysis incident & prevalent hemodialysis patients,1997 1999 combined The rates of admissions for infection vary little between the genders. Among age groups, however, rates are highest for children younger than ten years of age who have had ESRD for less than one year, and for children aged 5 9 who have had ESRD less than five years. Admissions per 1 patient years at risk 14 12 1 8 6 4 2 Age < 1 year 1 to < 2 years 2 to <5 years 5+ years Gender -4 5-9 1-14 15-19 Figure 6.16 Admissions for infection (overall), by age, gender, & time on ESRD: peritoneal dialysis incident & prevalent peritoneal dialysis patients, 1997 1999 combined In all age and gender groups except ages 5 9, pediatric patients on peritoneal dialysis have higher rates of admission for infection than their counterparts on hemodialysis. Rates are highest for the youngest patients (ages 4), and for children aged 5 9 who have had ESRD for more than five years. s have slightly higher admission rates than males, and these rates increase with longer patient vintages. Admissions per 1 patient years at risk 14 12 1 8 6 4 2 Age < 1 year 1 to < 2 years 2 to <5 years 5+ years -4 5-9 1-14 15-19 Gender Figure 6.17 Admissions for infection (overall), by age, gender, & time on ESRD: transplant incident & prevalent transplant patients, Transplant-related admissions for infection in pediatric patients are the lowest within all modalities, at about half of those of the other dialytic therapies. Age is a significant factor, with transplant patients younger than ten having higher infectious hospitalization rates than their older counterparts. Admissions per 1 patient years at risk 8 7 6 5 4 3 2 1 Age < 1 year 1 to < 2 years 2 to <5 years 5+ years Gender -4 5-9 1-14 15-19

CHAPTER 6 ž PEDIATRIC ESRD ž 115 Deaths per 1, patient years at risk 14 12 1 8 6 4 2 Figure 6.18 Causes of death, by gender: hemodialysis prevalent patients aged 19, The other known category accounts for the highest number of deaths in pediatric patients on hemodialysis. Death rates are higher for females than for males in this category, cardiac other, and infectious death. Deaths per 1, patient years at risk 2 16 12 8 4 Figure 6.19 Causes of death, by gender: peritoneal dialysis prevalent patients aged 19, patients on peritoneal dialysis have a more than fourfold difference in rates of death due to cardiac arrest compared to their male counterparts. They also have higher rates of death due to infection and to other cardiac and other known causes. Deaths per 1, patient years at risk 4 3 2 1 Figure 6.2 Causes of death, by gender: transplant prevalent patients aged 19, While mortality rates for pediatric patients with transplants are low, girls again have higher rates than boys in many categories. s do have higher rates of mortality due to infection and other known causes. Transplant centers frequently do not receive notification about the deaths of patients who are followed by the primary care doctors. Because graft survival is longest in pediatric patients, causes of death for these patients are frequently unreported.

116 ž 21 ATLAS OF ESRD IN THE UNITED STATES Figure 6.21 Causes of death, by race: hemodialysis prevalent patients aged 19, Because of the small number of patients, data are not shown for Native American or Asian patients. The rate of mortality due to cardiac arrest is almost three times higher among black pediatric patients on hemodialysis than in their white counterparts. White patients, however, have slightly higher rates of death due to infection and to other cardiac and other known causes. Deaths per 1, patient years at risk 15 12 9 6 3 White Black Figure 6.22 Causes of death, by race: peritoneal dialysis prevalent patients aged 19, Because of the small number of patients, data are not shown for Native American or Asian patients. In contrast to rates in the hemodialysis population, rates of mortality due to cardiac arrest show little difference between the races for pediatric patients on peritoneal dialysis. Mortality due to infection or to other known causes is more frequent among black patients, while deaths related to cerebrovascular or to other cardiac events occur more often in white patients. Deaths per 1, patient years at risk 15 12 9 6 3 White Black Figure 6.23 Causes of death, by race: transplant prevalent patients aged 19, Because of the small number of patients, data are not shown for Native American or Asian patients. Black patients have higher mortality rates on transplant for all causes of death except other known; in several categories (cardiac other, cerebrovascular, and infection) rates for blacks are more than twice as high as those for whites. Deaths per 1, patient years at risk 4 3 2 1 White Black